The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tappas: An adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (AAS).
 
Robin Lewis Jones
Consulting or Advisory Role - Adaptimmune; Daiichi Sankyo; Eisai; Immodulon Therapeutics; Immune Design; Lilly; Merck Serono; Morphotek; TRACON Pharma
Research Funding - GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Steven Attia
Consulting or Advisory Role - EMD Serono; Karyopharm Therapeutics
Research Funding - AB Science (Inst); Bayer (Inst); Bayer (Inst); CytRx Corporation (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); Immune Design (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Novartis (Inst); Threshold Pharmaceuticals (Inst); TRACON Pharma (Inst); ZIOPHARM Oncology (Inst)
 
Cyrus R. Mehta
No Relationships to Disclose
 
Lingyun Liu
No Relationships to Disclose
 
Kamalesh Kumar Sankhala
No Relationships to Disclose
 
Steven Ian Robinson
Research Funding - Tricon Pharmaceuticals
Travel, Accommodations, Expenses - Tricon Pharmaceuticals
 
Vinod Ravi
No Relationships to Disclose
 
Nicolas Penel
No Relationships to Disclose
 
Silvia Stacchiotti
Honoraria - Lilly; PharmaMar; Takeda
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Karyopharm Therapeutics; Lilly; PharmaMar; Plexxikon
Research Funding - Amgen (Inst); Bayer (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
William D. Tap
Consulting or Advisory Role - Adaptimmune; Daiichi Sankyo; Eisai; EMD Serono; Immune Design; Janssen; Lilly; Novartis; Plexxikon; TRACON Pharma
 
Delia Alvarez
Employment - Tricon Pharmaceuticals
Stock and Other Ownership Interests - Tricon Pharmaceuticals
 
Richard Yocum
Employment - Sophiris Bio
Stock and Other Ownership Interests - Sophiris Bio
Consulting or Advisory Role - Gilead Sciences; LAM Therapeutics; Sophiris Bio; Tricon Pharmaceuticals
 
Charles P. Theuer
Employment - Tricon Pharmaceuticals
Leadership - TRACON Pharma
Stock and Other Ownership Interests - Tricon Pharmaceuticals
 
Robert G. Maki
Honoraria - Lilly
Consulting or Advisory Role - AADi; Arcus Ventures; Bayer; Eisai; Gem Pharmaceuticals; Immune Design; Karyopharm Therapeutics; Lilly/ImClone; Presage Biosciences; SARC: Sarcoma Alliance for Research though Collaboration; TRACON Pharma
Research Funding - Immune Design (Inst); Lilly (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Uptodate: I write and edit chapters for their online text book.
Travel, Accommodations, Expenses - Bayer/Onyx; Immune Design; TRACON Pharma